Development of a Pharmacogenetic Predictive Test in asthma: Proof of concept

Pharmacogenetics and Genomics

Volumn 20, Issue 2, 2010, Pages 86-93

  Wu, Ann Chen ^a,b   Himes, Blanca E ^c,d,f   Lasky Su, Jessica ^c   Litonjua, Augusto ^c   Li, Lingling ^a   Lange, Christoph ^e   Lima, John ^g   Irvin, Charles G ^h   Weiss, Scott T ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Children's Hospital   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Children's Hospital Informatics Program   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^g NEMOURS CHILDREN S CLINIC   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; Bronchodilator response; Personalized medicine; Pharmacogenetic test; Predictive medicine

Indexed keywords

SALBUTAMOL; THEOPHYLLINE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CHILD; DIAGNOSTIC TEST; DRUG MONITORING; FAMILY STUDY; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN GENOME; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACOGENETIC PREDICTIVE TEST; PHARMACOGENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; AREA UNDER CURVE; ASTHMA; CHILD; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; ROC CURVE;

EID: 75649088886     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32833428d0     Document Type: Article

References (38)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
2. Venter JC, Adams MD, Myers EW, Li PW, Mural MJ, Sutton GG, et al. The sequence of the human genome. Science 2001; 291:1304-1351.
3. Christensen K, Murray JC. What genome-wide association studies can do for medicine. N Engl J Med 2007; 356:1094-1097.
4. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N Engl J Med 2008; 358:105-107.
5. Tantisira K, Weiss S. The pharmacogenetics of asthma treatment. Curr Allergy Asthma Rep 2009; 9:10-17.
6. Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001; 285:540-544.
7. Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999; 353:717-719.
8. D'Andrea G, D'Ambrosio RL, Di Perna P, Chetta M, Santacroce R, Brancaccio V, et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 2005; 105:645-649.
9. Vandekerckhove L, Blot S, Vogelaers D. Abacavir hypersensitivity. N Engl J Med 2008; 358:2514-2515.
10. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004; 59:469-478.
11. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000; 56:1054-1070.
12. Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, et al. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008; 122:921-928. e924.
13. Morgan DJ. Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet 1990; 18:270-294.
14. Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. Forced expiratory volume in 1 s percentage improves the classification of severity among children with asthma. Pediatrics 2006; 118:e347-e355.
15. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339.
16. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162:75-80.
17. Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999; 65:519-525.
18. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
19. Litonjua AA. The significance of beta2-adrenergic receptor polymorphisms in asthma. Curr Opin Pulm Med 2006; 12:12-17.
20. Weiss ST, McLeod HL, Flockhart DA, Dolan ME, Benowitz NL, Johnson JA, et al. Creating and evaluating genetic tests predictive of drug response. Nat Rev Drug Discov 2008; 7:568-574.
21. Elston RC. The genetic dissection of multifactorial traits. Clin Exp Allergy 1995; 25 (Suppl 2):103-106.
22. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003; 72:636-649.
23. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006; 3:e374.
24. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. Using the noninformative families in family-based association tests: a powerful new testing strategy. Am J Hum Genet 2003; 73:801-811.
25. Lange C, DeMeo DL, Laird NM. Power and design considerations for a general class of family-based association tests: quantitative traits. Am J Hum Genet 2002; 71:1330-1341. (Pubitemid 36015888)
26. Lange C, Laird NM. On a general class of conditional tests for family-based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations. Genet Epidemiol 2002; 23:165-180.
27. Van Steen K, McQueen MB, Herbert A, Raby B, Lyon H, Demeo DL, et al. Genomic screening and replication using the same data set in family-based association testing. Nat Genet 2005; 37:683-691.
28. Litonjua AA, Lasky-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008; 178:688-694.
29. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49:1373-1379.
30. The Childhood Asthma Management Program Research Group. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007; 175:235-242.
31. American Lung Association Asthma Clinical Research Centers. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054-1063.
32. Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 2000; 55:762-767.
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
34. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005; 38:404-415.
35. Development Core Team. R: a language and environment for statistical computing. Vienna, Austria 2007.
36. Lu Q, Elston RC. Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet 2008; 82:641-651.
37. Litonjua AA, Tantisira KG, Lasky-Su JA, Murphy A, Lazarus R, Klanderman B, et al. Genome-wide association analysis of bronchodilator response in asthma (abstract). Am J Respir Crit Care Med 2008.
38. Barrientos T, Frank D, Kuwahara K, Bezprozvannaya S, Pipes GC, Bassel-Duby R, et al. Two novel members of the ABLIM protein family, ABLIM-2 and-3, associate with STARS and directly bind F-actin. J Biol Chem 2007; 282:8393-8403.